Former regulatory scientist at Voisin Consulting Life Sciences in Paris. Currently working in business development at Institut Curie in big data, genomic and bioinformatic tech transfer and industrial partnerships. He describes himself as an innovative tech and therapies addict, interested in innovative health and digital tech, traveling, sports, video games and RPGs, and drawing.

Articles by Timothé Cynober

In Depth 27 Jan 2021

Single-Cell Sequencing: Paving the Way for Precision Medicine

In Depth 27 Jul 2020

Biosensors: Monitoring Our Health Anywhere, Anytime

In Depth 1 Jun 2020

How Personal Genomics Companies Are Changing Drug Development

In Depth 17 Jun 2019

Artificial Intelligence in Oncology: Fantasy or Reality?

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

In Depth 14 May 2018

Could Stem Cells Replace Animal Testing in Drug Development?

How to Deal with Regulations to Get Approval for CAR-T Cells

In Depth 20 Jul 2017

SHIVA Trial: France’s Big Shot at Precision Medicine for Cancer

In Depth 12 Jul 2017

Genomic Testing in Oncology: From Single Genes to Whole Genomes

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail